genetikode
Team
Our team combines expertise in translational oncology, diagnostics commercialization, computational biology, and AI-enabled healthcare innovation. Together, we are building products that translate deep science into real-world precision oncology impact.
Core Team
Chief Executive Officer
Experienced in leading high-growth healthcare and biotechnology ventures, building scalable diagnostic platforms, and driving strategic expansion across research, clinical, and commercial domains. Committed to advancing next-generation oncology and personalized healthcare by integrating scientific excellence, digital innovation, and patient-centered impact.
Chief Technology Officer
A cancer genomics scientist whose work spans translational oncology, epigenetics, and using artificial intelligence in solving healthcare problems. His publication record reflects a strong focus on molecular mechanisms of cancer progression, including tumor genomics, alternative splicing, and clinically relevant biomarker discovery in solid tumors.
Chief Business Officer
Has strategic leadership in scaling NGS diagnostics businesses at the intersection of precision medicine, commercial growth, and AI/ML-driven innovation. Experienced in building partnerships, expanding market access, and translating advanced genomic and data science capabilities into clinically and commercially impactful solutions. Focused on accelerating growth through intelligent diagnostics, digital health integration, and business models that advance personalized oncology and next-generation healthcare.
Advisory Board
Associate Director Translational Oncology Bioinformatics
AI x Biotech Strategist | Oncology & Immunotherapy Expert | Bridging Science, Investment & Innovation | Driving the Future of Drug Discovery | Immunotherapy Advocate | Art & Yoga Enthusiast
Professor at Jilin University, China
Professor at The University of Osaka
Laboratory Manager at Pure Health, Abu Dhabi, UAE CoE Genomics, PureLab, STMC, Al Ain, UAE